Pendium
Pricing
Get a demo
Dashboard
Dashboard
Loading…
/

Teach AI agents to recommend your brand to the right people.

Scan your visibilityBook a demo
Pendium
𝕏

Product

AI Visibility ScanYelp Listing AuditSite AuditContent for AI AgentsAgent Experience EngineAgent AnalyticsPricing

Industries

Local BusinessesRestaurantsHome ServicesBeauty & SpasHealth & MedicalFitness & GymsPet ServicesContractorsBars & NightlifeMoving CompaniesAuto DealershipsSaaS CompaniesSEO TeamsMarketing Teams

Tools

AI Visibility Site ScanYelp Listing AuditGBP AuditSocial Presence AuditBlog That Writes Itself

Real Life Examples

RipplingMasterclassThorneMonday.comPatagonia

Company

AboutBook a DemoDocsPrivacy PolicyTerms of Service
© 2026 Manifest Labs. All rights reserved.
PrivacyTerms
Rhizome AI
Rhizome AI
Visibility34
Vibe91
Businesses/Healthcare Technology/Rhizome AI
Rhizome AI
AI Visibility & Sentiment

Rhizome AI

Rhizome AI is a regulatory intelligence platform that enables pharmaceutical and biotech professionals to instantly answer complex FDA and regulatory questions by referencing thousands of authoritative documents without hallucinations. The AI-powered tool provides comprehensive, citation-backed research across 30 regulatory and clinical datasets from 6 global markets.

Active Monitoring
rhizomeai.com
Healthcare TechnologyYC25-26
AI Visibility Score
34/100

Low

Sentiment Score
91/100
Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core
34
adjacent
0
OverviewLandscapeInsights & ActionsConversationsCitationsBrand Voice

Is this your business?

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe Rhizome AI today.

Rhizome AI has achieved elite-level authority within Claude and Gemini, frequently securing the #1 position for regulatory research, yet it remains a complete ghost in Google AI Overviews. While the brand dominates the enterprise regulatory strategist persona, it is suffering from a total visibility blackout among lean biotech R&D directors and within the ChatGPT ecosystem.

Working in your favor

Exceptional performance on Gemini and Claude with average positions of 1.5 and 2.2 respectively.

High authority in 'Accelerated Regulatory Research' queries, specifically for FDA guidance and document summarization.

Strong resonance with the Enterprise Regulatory Strategist persona, achieving a 60% mention rate.

Gaps to close

Zero visibility (0%) across AI Overviews and Lean Biotech R&D Director personas.

Significant underperformance on ChatGPT with a mention rate of only 11% and a lagging average position of 17.0.

Total absence in 'Global Compliance' and 'Clinical Trial Strategy' query sets where incumbents like Citeline and RegDesk currently lead.

Opportunities

Displace legacy competitors like Cortellis and Citeline in global medical device rule comparisons where Rhizome is currently unranked.

Leverage existing high sentiment on Claude to build a citation bridge into Google Search and AI Overviews.

Capture the underserved 'Boutique Regulatory Consultant' market by expanding documentation on niche EMA and FDA guidance search capabilities.

Highest-Impact Actions
1

Address the ChatGPT visibility gap by optimizing technical documentation and case studies for LLM indexing.

An average position of 17.0 on ChatGPT indicates that while the model knows of the brand, it does not view it as a primary authority compared to competitors like Citeline.

2

Develop content specifically targeting 'Clinical Trial Strategy' and 'Endpoint Analysis' keywords.

Rhizome is currently invisible in these high-intent query groups, allowing competitors to claim the 'intelligence' narrative in the clinical space.

3

Implement a structured data strategy to trigger Google AI Overviews for 'FDA guidance search' queries.

Rhizome has 0% visibility in AI Overviews despite being a top-ranked tool in Gemini, suggesting a disconnect in how Google's search-based AI indexes the brand's core value proposition.

Value Proposition

Hallucination-free AI research that cites up to 1,000 documents from trusted regulatory databases, enabling regulatory professionals to get accurate answers in minutes instead of weeks of manual research

Overview

Rhizome AI is a regulatory intelligence platform that enables pharmaceutical and biotech professionals to instantly answer complex FDA and regulatory questions by referencing thousands of authoritative documents without hallucinations. The AI-powered tool provides comprehensive, citation-backed research across 30 regulatory and clinical datasets from 6 global markets.

Mission

To ensure regulatory professionals always have accurate, trustworthy answers to their FDA and regulatory questions

Products & Services
AI-powered regulatory question answeringFDA document search and analysisEMA regulatory database accessClinical trial guidance researchMulti-market regulatory intelligence
Current State

Visibility Landscape

A high-level view of how Rhizome AI performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

ChatGPTChatGPT
ClaudeClaude
GeminiGemini
AI OverviewsAI Overviews

Reputation1q

Brand recognition & direct queries

97
97
70
97
“What do you know about Rhizome AI? What do they do and what's their reputation?”
#1
#1
Yes
#1

Core4q

Product/service category queries

23
77
96
0
“best way to search fda guidance for cmc changes for biologics without doing it all manually”
#17
#1
#1
No
“how can i compare fda and ema medical device rules quickly using ai”
No
No
#1
No
“best reviewed regulatory intelligence platforms for small biotech firms right now”
No
#4
#2
No
“help me find a tool that can summarize thousands of fda transcripts without making stuff up”
—
#1
#1
No

Growth Areas1q

Adjacent, aspirational & visionary

0
0
0
0
“how to find specific clinical trial endpoints from recent fda drug approvals”
No
No
No
No
ChatGPT
Claude
Gemini
AI Overviews

“What do you know about Rhizome AI? What do they do and what's their reputation?”

ChatGPT#1
Claude#1
GeminiYes
AI Overviews#1

“best way to search fda guidance for cmc changes for biologics without doing it all manually”

ChatGPT#17
Claude#1
Gemini#1
AI OverviewsNo

“how can i compare fda and ema medical device rules quickly using ai”

ChatGPTNo
ClaudeNo
Gemini#1
AI OverviewsNo

“best reviewed regulatory intelligence platforms for small biotech firms right now”

ChatGPTNo
Claude#4
Gemini#2
AI OverviewsNo

“help me find a tool that can summarize thousands of fda transcripts without making stuff up”

ChatGPT—
Claude#1
Gemini#1
AI OverviewsNo

“how to find specific clinical trial endpoints from recent fda drug approvals”

ChatGPTNo
ClaudeNo
GeminiNo
AI OverviewsNo
Competitive Landscape
1
Citeline
12 mentions
2
Rhizome AI
12 mentions
3
RegDesk
10 mentions
4
Cortellis
9 mentions
5
Clarivate
8 mentions
6
AgencyIQ
7 mentions
7
Weaviate
6 mentions
8
POLITICO
6 mentions
9
Veeva Vault RIM
6 mentions
10
Pinecone
5 mentions
11
Cortellis Regulatory Intelligence
5 mentions
Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve Rhizome AI's AI visibility.

Key Findings

Strength

Exceptional performance on Gemini and Claude with average positions of 1.5 and 2.2 respectively.

Strength

High authority in 'Accelerated Regulatory Research' queries, specifically for FDA guidance and document summarization.

Strength

Strong resonance with the Enterprise Regulatory Strategist persona, achieving a 60% mention rate.

Recommended Actions

1

Address the ChatGPT visibility gap by optimizing technical documentation and case studies for LLM indexing.

An average position of 17.0 on ChatGPT indicates that while the model knows of the brand, it does not view it as a primary authority compared to competitors like Citeline.

2

Develop content specifically targeting 'Clinical Trial Strategy' and 'Endpoint Analysis' keywords.

Rhizome is currently invisible in these high-intent query groups, allowing competitors to claim the 'intelligence' narrative in the clinical space.

3

Implement a structured data strategy to trigger Google AI Overviews for 'FDA guidance search' queries.

Rhizome has 0% visibility in AI Overviews despite being a top-ranked tool in Gemini, suggesting a disconnect in how Google's search-based AI indexes the brand's core value proposition.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPTChatGPTClaudeClaudeGeminiGeminiAI OverviewsAI Overviews
Accelerated Regulatory Research(2 queries)

“best way to search fda guidance for cmc changes for biologics without doing it all manually”

0/4 platforms mentioned

Core
ChatGPTChatGPT
1.Google Alerts
2.Google Custom Search
3.Bing Search API
4.Google Programmable Search Engine
5.Bing Web Search API

+20 more

ClaudeClaude
1.RegDox
2.Compliance.ai
3.Veeva Vault
4.Benchling
5.RAPS

+1 more

GeminiGemini
1.Cortellis Regulatory Intelligence
2.Clarivate
3.Veeva Vault Regulatory Information Management
4.Veeva
5.AgencyIQ

+8 more

AI OverviewsAI Overviews

No brands listed

“help me find a tool that can summarize thousands of fda transcripts without making stuff up”

2/3 platforms mentioned

Core
The Enterprise Regulatory Strategist · SVP of Regulatory Affairs
ClaudeClaude
1.Rhizome AI
2.LexisNexis+ AI
3.Synthesis.com
4.LlamaIndex
5.GPT-4
GeminiGemini
1.GPT-4
2.Rhizome AI
3.Clarivate Cortellis
4.Hebbia
5.Expert.ai

+1 more

AI OverviewsAI Overviews
1.Eleos Health
2.HData
3.Lexis+
4.Protégé
5.CoCounsel

+9 more

Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

FDA's official guidance database

fda.gov

Gov1 ref

Search for FDA Guidance Documents

fda.gov

Gov1 ref

CMC Postapproval Manufacturing Changes for Specified ...

fda.gov

Gov1 ref

CMC and GMP Guidances - FDA

fda.gov

Gov1 ref

Comparability Protocols for Postapproval Changes to the Chemistry, ...

fda.gov

Gov1 ref

Chemistry, Manufacturing, and Controls Changes to an ...

fda.gov

Gov1 ref

Manufacturing Changes and Comparability for Human CGT Products

fda.gov

Gov1 ref

Guidance, Compliance & Regulatory Information (Biologics)

fda.gov

Gov1 ref

Chemistry, Manufacturing, and Controls Changes to an ...

federalregister.gov

Gov1 ref

fda.gov

fda.gov

Gov1 ref

eur-lex.europa.eu

eur-lex.europa.eu

Web1 ref

ec.europa.eu/health/md_sector/new_regulations_en

ec.europa.eu

Web1 ref

The future of AI regulation in drug development - PMC - NIH

pmc.ncbi.nlm.nih.gov

Gov1 ref

The future of AI regulation in drug development: a comparative ...

academic.oup.com

Web1 ref

Global Harmonization of Artificial Intelligence-Enabled Software as a ...

pmc.ncbi.nlm.nih.gov

Gov1 ref
Brand Identity

Brand Voice & Style

How AI perceives Rhizome AI's communication style and personality

Rhizome AI communicates with confident expertise and technical precision, speaking directly to regulatory professionals who value accuracy above all else. The tone is professional and authoritative yet accessible, avoiding jargon while demonstrating deep domain knowledge. The brand emphasizes trustworthiness and reliability, frequently highlighting their zero-hallucination track record. There's an underlying sense of empowerment—helping users accomplish weeks of work in minutes—delivered with understated confidence rather than hype.

Core Tone Traits

Authoritative & Expert

Demonstrates deep regulatory domain knowledge and FDA expertise

Trustworthy & Precise

Emphasizes accuracy, citations, and hallucination-free results

Professional yet Accessible

Technical content delivered in clear, understandable language

Empowering & Efficient

Focuses on time savings and enabling professionals to do their best work

Visual Identity

Primary

#1E40AF

Secondary

#FFFFFF

Accent

#3B82F6

Background

#FFFFFF

Foreground

#111111

Backing

Investors

Y
Y Combinator

Engineer content that makes AI agents recommend you

Pendium analyzes how AI platforms perceive your brand, reverse-engineers what they already cite, and continuously publishes content designed to fill gaps and earn more mentions — on autopilot, with you in the loop.

Data generated by Pendium.ai AI visibility scanning. Last scanned February 27, 2026.

Explore Healthcare Technology

View all
Zocdoc
Zocdoc
82/100
Biobot Analytics
Biobot Analytics
80/100
Spruce Health
Spruce Health
76/100
Honor
Honor
75/100
Ambience Healthcare
Ambience Healthcare
73/100
Verifiable
Verifiable
69/100
Roo
Roo
68/100
Headway
Headway
68/100
Adonis
Adonis
57/100
Trellis AI
Trellis AI
51/100
Pearl Health
Pearl Health
48/100
Symmetric Health Solutions, LLC
Symmetric Health Solutions, LLC
46/100

Start getting
recommended by AI.

Enter your website to see exactly what ChatGPT, Claude, and Gemini say about your business. Free, instant, and eye-opening.

Free visibility scanResults in 2 minutesNo credit card required

Frequently asked questions

Don't see your question? Book a demo and we'll walk you through it.

Rhizome AI is a regulatory intelligence platform that enables pharmaceutical and biotech professionals to instantly answer complex FDA and regulatory questions by referencing thousands of authoritative documents without hallucinations. The AI-powered tool provides comprehensive, citation-backed research across 30 regulatory and clinical datasets from 6 global markets.

Hallucination-free AI research that cites up to 1,000 documents from trusted regulatory databases, enabling regulatory professionals to get accurate answers in minutes instead of weeks of manual research

AI Visibility Score

Rhizome AI has an AI visibility score of 34/100, rated as low. This score reflects how often and how prominently Rhizome AI appears in responses from AI assistants like ChatGPT, Claude, and Gemini.

AI Perception Summary

Rhizome AI has achieved elite-level authority within Claude and Gemini, frequently securing the #1 position for regulatory research, yet it remains a complete ghost in Google AI Overviews. While the brand dominates the enterprise regulatory strategist persona, it is suffering from a total visibility blackout among lean biotech R&D directors and within the ChatGPT ecosystem.

Strengths

  • Exceptional performance on Gemini and Claude with average positions of 1.5 and 2.2 respectively.
  • High authority in 'Accelerated Regulatory Research' queries, specifically for FDA guidance and document summarization.
  • Strong resonance with the Enterprise Regulatory Strategist persona, achieving a 60% mention rate.

Visibility Gaps

  • Zero visibility (0%) across AI Overviews and Lean Biotech R&D Director personas.
  • Significant underperformance on ChatGPT with a mention rate of only 11% and a lagging average position of 17.0.
  • Total absence in 'Global Compliance' and 'Clinical Trial Strategy' query sets where incumbents like Citeline and RegDesk currently lead.

Competitors in AI Recommendations

  • Citeline: 12 mentions
  • RegDesk: 10 mentions
  • Cortellis: 9 mentions
  • Clarivate: 8 mentions
  • AgencyIQ: 7 mentions
  • Weaviate: 6 mentions
  • POLITICO: 6 mentions
  • Veeva Vault RIM: 6 mentions
  • Pinecone: 5 mentions
  • Cortellis Regulatory Intelligence: 5 mentions
  • Veeva Vault: 5 mentions
  • RAPS: 5 mentions
  • Veeva: 4 mentions
  • Pharmaprojects: 4 mentions
  • Clarivate Cortellis: 4 mentions

Categories: Healthcare Technology

Tags: YC25-26